EP1803820B1 - A process for the preparation of vitamin K2 - Google Patents

A process for the preparation of vitamin K2 Download PDF

Info

Publication number: EP1803820B1
Authority: EP; European Patent Office
Prior art keywords: vitamin; bacillus subtilis; dsm; fermentation; culture
Prior art date: 2005-12-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

EP05425932A

Other languages

German (de)

English (en)

French (fr)

Other versions

EP1803820A1 (en

Inventor

Alberto Benedetti

Simona Daly

Roberto Xaiz

Hermes Pagani

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Gnosis SpA

Original Assignee

Gnosis SpA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-29

Filing date

2005-12-29

Publication date

2009-06-24

2005-12-29 Priority to DK05425932T priority Critical patent/DK1803820T3/da

2005-12-29 Application filed by Gnosis SpA filed Critical Gnosis SpA

2005-12-29 Priority to DE602005015133T priority patent/DE602005015133D1/de

2005-12-29 Priority to SI200530735T priority patent/SI1803820T1/sl

2005-12-29 Priority to PT05425932T priority patent/PT1803820E/pt

2005-12-29 Priority to ES05425932T priority patent/ES2326379T3/es

2005-12-29 Priority to EP05425932A priority patent/EP1803820B1/en

2005-12-29 Priority to PL05425932T priority patent/PL1803820T3/pl

2005-12-29 Priority to RSP-2009/0359A priority patent/RS51172B/sr

2005-12-29 Priority to AT05425932T priority patent/ATE434666T1/de

2006-12-08 Priority to US11/635,768 priority patent/US7718407B2/en

2006-12-27 Priority to KR1020060135200A priority patent/KR101439473B1/ko

2006-12-28 Priority to CA2572373A priority patent/CA2572373C/en

2006-12-28 Priority to JP2006354565A priority patent/JP5043425B2/ja

2007-07-04 Publication of EP1803820A1 publication Critical patent/EP1803820A1/en

2009-06-24 Application granted granted Critical

2009-06-24 Publication of EP1803820B1 publication Critical patent/EP1803820B1/en

2009-08-05 Priority to CY20091100829T priority patent/CY1109266T1/el

2009-09-24 Priority to HR20090507T priority patent/HRP20090507T1/hr

2025-12-29 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/66—Preparation of oxygen-containing organic compounds containing the quinoid structure
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Definitions

the present invention concerns the fermentative production of vitamin K2 (menaquinone - 7: MK - 7), using a Bacillus microorganism.
the invention concerns a mutant of the microorganism Bacillus subtilis deposited under the Budapest Treaty, which is able to produce MK - 7 in high amounts, under specific culture conditions.
Vitamin K is an essential cofactor for the formation of ⁇ -carboxyglutamic acid (Gla) residues in proteins (Olson, R.E., 1984 1 - Suttie, J.W., 1985 2 ).
the Gla - containing proteins bind calcium ions and influence, for example, blood coagulation and tissue calcification (e.g., osteocalcin found in bone tissues) (Hauschka P.V. et al. 1978 3 - Price, P.A. et al., 1976 4 ).
Vitamin K deficiency has been implicated in several clinical ailments such as intracranial hemorrhage in newborn infants (Ferland, G. et al., 1993 5 - Shearer, M.J., 1995 6 ) and possible bone fracture resulting from osteoporosis (Knapen, M.H. et al., 1989 7 ).
Vitamin K occurs naturally in two forms, namely, K1 (phylloquinone) in green plants and K2 (menaquinones -MK) in animals and some bacteria (Collins, M.D. et al., 1981 8 - Conly, J.M. et al. 1992 9 - Ramotar, K. et al., 1984 10 - Taber, H. 1980 11 - Watanuki, M. et al. 1972 12 ), including intestinal bacteria.
MK has a variable side chain length of 4 - 13 isoprene units. They are referred to as MK - ⁇ , where ⁇ denotes the number of isoprenoid residues.
the MK are constituents of the bacterial plasma membrane and function as redox reagents in electron transport and oxidative phosphorylation systems (Taber, H. 1980 - Ramotar, K. et al. 1984).
Lactic acid bacteria have been used as starter cultures to manufacture various foods and can be generally recognized as safe (GRAS), and a qualitative study has shown that some lactic acid bacteria produce MK. In many countries, the daily requirement for vitamin K is around 1 ⁇ g/kg of body weight.
Yoshinori Tsukamoto et al. (2001) have recovered a analogous resistant mutant of B. subtilis "natto" having productivity of 1719 ⁇ g/100 g dry weight.
K2 (MK - 7) is produced in amounts of 1.0 ⁇ g/g dry weight or below ( US 2004/043015 ; US 2005/0025759 ; US 2002/0146786 ; US 2001/0046697 ).
Bacillus subtilis mutated strain having productivity ranging from 1,000 to 25,000 ppm of dry matter, with a production cycle (from pre-seed to fermentation) of 160 - 200 hours, more precisely 170 - 185 hours.
the Bacillus subtilis mutant GN13/72 was obtained by treatments with NTG or, alternatively, U.V. and recovered on a micronised soy meal solid medium.
the strain was deposited under the terms of the Budapest Treaty at the Deutsche Sammlung von Mikrorganismen und Zellkulturen (DSMZ) on December 5, 2005 under the accession number DSM 17766.
the MK - 7 high-content biomass is prepared according to known fermentation techniques by means of culture media containing carbon sources (such as glucose, saccharose, glycerol, starch hydrolysate and the like); nitrogen sources (such as yeast extract or autolysate, peptones of various origin, soy meal and the like); various salts (such as potassium phosphate, sodium chloride, magnesium sulfate, manganese sulfate, zinc sulfate, and the like).
carbon sources such as glucose, saccharose, glycerol, starch hydrolysate and the like
nitrogen sources such as yeast extract or autolysate, peptones of various origin, soy meal and the like
various salts such as potassium phosphate, sodium chloride, magnesium sulfate, manganese sulfate, zinc sulfate, and the like.
the biomass is collected by centrifugation or microfiltration, washed twice with purified water and resuspended in purified water.
the resulting creams are dried by freeze-drying or spray-drying, then packaged under vacuum.
Bacillus subtilis GN13/27 - DSM 17766 is aerobically grown in a 30 l (geometrical) fermenter containing 20 l of "F10" fermentation medium having the following composition:
the fermenter is inoculated with 8% (1600 ml) of 16h ( ⁇ 2 h) seed, whose "S3" medium has the following composition:
the seed was in turn inoculated with 5 ml of B. subtilis suspension from a slant washed with 10 ml of purified water.
the biomass obtained under said conditions was 8 ( ⁇ 1) g/l dry weight with MK - 7 content of 1100 ( ⁇ 100) ppm.
Bacillus subtilis GN13/72 - DSM 17766 is cultured as in Example 1, the "F12" fermentation medium having the following composition:
Bacillus subtilis GN13/72 - DSM 17766 is cultured as in Example 1, the "F13" fermentation medium having the following composition:
Bacillus subtilis GN13/72 - DSM 17766 is cultured as in Example 3, the carbon source consisting of maltodextrin instead dextrin. Duration of the fermentation 140 h ( ⁇ 3 h). 8.0 ( ⁇ 1.0) g/l dry weight are obtained with MK - 7 content of 8500 ( ⁇ 150) ppm.
Bacillus subtilis GN13/72 - DSM 17766 is cultured as in Example 4, the antifoam agent being soybean oil. Duration of the fermentation 144 h ( ⁇ 4 h). 11 ( ⁇ 1) g/l dry weight are obtained with MK - 7 content of 11700 ( ⁇ 300) ppm.
Bacillus subtilis GN13/72 - DSM 17766 is cultured in a 300 l fermenter, with 225 l useful volume, medium "F13", pH automatically kept at 7.2 ( ⁇ 0.1) with NaOH; stirring 100 rpm; air 0.5 vvm; pressure 0.3 bar; antifoam soybean oil automatically controlled.
Inoculum was 4% obtained in a seed of 30 l total with 20 l useful volume and "S3" medium (see Example 1).
the biomass was divided into 2 parts: a part was freeze-dried to obtain a powder having 17000 ( ⁇ 350) ppm; the other part was spray-dried to obtain 20000 ( ⁇ 500) ppm.
Example 7 The procedure of Example 7.is followed, in which the fermentation useful volume was 2 m 3 .
the spray-dried final product was packaged in 250 g sachets under vacuum.

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

EP05425932A 2005-12-29 2005-12-29 A process for the preparation of vitamin K2 Expired - Lifetime EP1803820B1 (en)

Priority Applications (15)

Application Number	Priority Date	Filing Date	Title
DE602005015133T DE602005015133D1 (de)	2005-12-29	2005-12-29	Verfahren zur Herstellung von Vitamin K2
SI200530735T SI1803820T1 (sl)	2005-12-29	2005-12-29	Postopek za pripravo vitamina k2
PT05425932T PT1803820E (pt)	2005-12-29	2005-12-29	Processo para a preparação de vitamina k2
ES05425932T ES2326379T3 (es)	2005-12-29	2005-12-29	Procedimiento para la preparacion de vitamina k2.
EP05425932A EP1803820B1 (en)	2005-12-29	2005-12-29	A process for the preparation of vitamin K2
PL05425932T PL1803820T3 (pl)	2005-12-29	2005-12-29	Sposób wytwarzania witaminy K2
RSP-2009/0359A RS51172B (sr)	2005-12-29	2005-12-29	Proces za pripremanje vitamina k2
AT05425932T ATE434666T1 (de)	2005-12-29	2005-12-29	Verfahren zur herstellung von vitamin k2
DK05425932T DK1803820T3 (da)	2005-12-29	2005-12-29	Fremgangsmåde til fremstilling af vitamin K2
US11/635,768 US7718407B2 (en)	2005-12-29	2006-12-08	Process for the preparation of vitamin K2
KR1020060135200A KR101439473B1 (ko)	2005-12-29	2006-12-27	비타민 ｋ２의 제조 방법
CA2572373A CA2572373C (en)	2005-12-29	2006-12-28	A process for the preparation of vitamin k2
JP2006354565A JP5043425B2 (ja)	2005-12-29	2006-12-28	ビタミンｋ２の製造方法
CY20091100829T CY1109266T1 (el)	2005-12-29	2009-08-05	Μεθοδος για την παρασκευη βιταμινης κ2
HR20090507T HRP20090507T1 (hr)	2005-12-29	2009-09-24	Postupak priprave vitamina k2

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP05425932A EP1803820B1 (en)	2005-12-29	2005-12-29	A process for the preparation of vitamin K2

Publications (2)

Publication Number	Publication Date
EP1803820A1 EP1803820A1 (en)	2007-07-04
EP1803820B1 true EP1803820B1 (en)	2009-06-24

Family

ID=36588821

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP05425932A Expired - Lifetime EP1803820B1 (en)	2005-12-29	2005-12-29	A process for the preparation of vitamin K2

Country Status (15)

Country	Link
US (1)	US7718407B2 (sr)
EP (1)	EP1803820B1 (sr)
JP (1)	JP5043425B2 (sr)
KR (1)	KR101439473B1 (sr)
AT (1)	ATE434666T1 (sr)
CA (1)	CA2572373C (sr)
CY (1)	CY1109266T1 (sr)
DE (1)	DE602005015133D1 (sr)
DK (1)	DK1803820T3 (sr)
ES (1)	ES2326379T3 (sr)
HR (1)	HRP20090507T1 (sr)
PL (1)	PL1803820T3 (sr)
PT (1)	PT1803820E (sr)
RS (1)	RS51172B (sr)
SI (1)	SI1803820T1 (sr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102010001832A1 (de)	2010-02-11	2011-08-11	Wacker Chemie AG, 81737	Verfahren zur fermentativen Herstellung von Menachinon-7 mit Escherichia coli

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0817528D0 (en) *	2008-09-24	2008-10-29	Syntavit As	Process
IN2009MU00380A (sr) *	2009-02-18	2010-04-02
DK2437758T3 (da) *	2009-06-03	2014-07-21	Chr Hansen As	Bakterie thyA(-) mutanter med forøget vitamin K
KR101196338B1 (ko) *	2010-06-16	2012-11-01	무주군약초영농조합법인	비타민 ｋ2 생성능이 높은 바실러스 아미로리퀴파시엔스 균주
JP2014150731A (ja) *	2013-02-05	2014-08-25	Fuji Oil Co Ltd	メナキノン−７含有食品および微生物によるメナキノン−７の製造法
WO2014131084A1 (en) *	2013-02-27	2014-09-04	The University Of Sydney	Fermentation and in situ extraction of menaquinones during microbial culture
JP6411586B2 (ja) *	2016-06-15	2018-10-24	アサヒグループホールディングス株式会社	骨代謝改善剤
KR101875502B1 (ko) *	2016-08-03	2018-07-09	민병규	ｐＨ－스탯 방식의 유가식 배양을 이용한 바실러스 서브틸리스 균주로부터 비타민 Ｋ２의 생산방법
US20220064678A1 (en) *	2018-12-11	2022-03-03	The Penn State Research Foundation	Method for production of vitamin k using biofilm reactors
CN110499345B (zh) *	2019-09-02	2021-05-28	福建康鸿生物科技有限公司	一种维生素k2(MK-7型)的发酵方法
KR102354881B1 (ko) *	2019-10-30	2022-02-07	주식회사 지에프퍼멘텍	한국 전통 청국장에서 분리된 초고순도 트랜스형 메나퀴논-7 고생산능을 가지는 신규한 바실러스 서브틸리스 균주 및 이의 용도
US11912654B2 (en)	2021-09-03	2024-02-27	Synergia Life Sciences Pvt. Ltd.	Process for stereospecific synthesis of vitamin K2 and its novel intermediates

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS4843877B1 (sr) *	1970-03-03	1973-12-21
ES2007758A6 (es) *	1987-12-07	1989-07-01	Espanola Petrol	Un procedimiento para la obtencion de alfa-amilasas termoestables, por cultivo de microorganismos superproductores a altas temperaturas.
US5024937A (en) *	1989-04-06	1991-06-18	Dow Corning Corporation	Method for processing aqueous fermentation broths
JPH069474B2 (ja) *	1990-03-20	1994-02-09	有限会社ビセイケン	アルコール耐性付与醗酵物の製造方法及びアルコール耐性付与醗酵食品
US5525695A (en) *	1991-10-15	1996-06-11	The Dow Chemical Company	Elastic linear interpolymers
JP3272657B2 (ja)	1998-01-19	2002-04-08	シャープ株式会社	スイッチング電源装置
JP4068103B2 (ja) *	1998-05-17	2008-03-26	洋行須見	雲南ｓｌ−００１菌の培養によるビタミンｋの生産方法
US6677141B2 (en) *	1998-05-17	2004-01-13	Honda Trading Corporation	Edible compositions of Bacillus subtilis natto cells containing water-soluble vitamin K
JP4104741B2 (ja) *	1998-09-08	2008-06-18	旭松食品株式会社	ビタミンｋ高生産性菌株及びそれを用いたビタミンｋの生産方法
JP4264159B2 (ja) *	1999-04-07	2009-05-13	株式会社ミツカングループ本社	ビタミンｋ２高生産性納豆菌、その育種方法及び納豆
JP2001346546A (ja) *	2000-06-08	2001-12-18	Kikkoman Corp	ビタミンｋ濃縮物の製造方法
JP2002034554A (ja) *	2000-07-28	2002-02-05	Mitsukan Group Honsha:Kk	ビタミンｋ２高生産納豆菌、その育種方法及び納豆
JP2005237300A (ja) *	2004-02-26	2005-09-08	Aichi Prefecture	食品素材及びその製造方法

2005
- 2005-12-29 RS RSP-2009/0359A patent/RS51172B/sr unknown
- 2005-12-29 PL PL05425932T patent/PL1803820T3/pl unknown
- 2005-12-29 AT AT05425932T patent/ATE434666T1/de active
- 2005-12-29 SI SI200530735T patent/SI1803820T1/sl unknown
- 2005-12-29 DE DE602005015133T patent/DE602005015133D1/de not_active Expired - Lifetime
- 2005-12-29 PT PT05425932T patent/PT1803820E/pt unknown
- 2005-12-29 DK DK05425932T patent/DK1803820T3/da active
- 2005-12-29 EP EP05425932A patent/EP1803820B1/en not_active Expired - Lifetime
- 2005-12-29 ES ES05425932T patent/ES2326379T3/es not_active Expired - Lifetime
2006
- 2006-12-08 US US11/635,768 patent/US7718407B2/en active Active
- 2006-12-27 KR KR1020060135200A patent/KR101439473B1/ko not_active Expired - Fee Related
- 2006-12-28 JP JP2006354565A patent/JP5043425B2/ja not_active Expired - Fee Related
- 2006-12-28 CA CA2572373A patent/CA2572373C/en active Active
2009
- 2009-08-05 CY CY20091100829T patent/CY1109266T1/el unknown
- 2009-09-24 HR HR20090507T patent/HRP20090507T1/hr unknown

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102010001832A1 (de)	2010-02-11	2011-08-11	Wacker Chemie AG, 81737	Verfahren zur fermentativen Herstellung von Menachinon-7 mit Escherichia coli
EP2360262A1 (de)	2010-02-11	2011-08-24	Wacker Chemie AG	Verfahren zur fermentativen Herstellung von Menachinon-7 mit Escherichia coli

Also Published As

Publication number	Publication date
CA2572373A1 (en)	2007-06-29
JP5043425B2 (ja)	2012-10-10
CA2572373C (en)	2014-02-04
US7718407B2 (en)	2010-05-18
ES2326379T3 (es)	2009-10-08
DK1803820T3 (da)	2009-10-12
HRP20090507T1 (hr)	2009-10-31
KR20070072383A (ko)	2007-07-04
PL1803820T3 (pl)	2009-12-31
PT1803820E (pt)	2009-07-14
CY1109266T1 (el)	2014-07-02
SI1803820T1 (sl)	2009-10-31
EP1803820A1 (en)	2007-07-04
DE602005015133D1 (de)	2009-08-06
JP2007181461A (ja)	2007-07-19
KR101439473B1 (ko)	2014-09-11
RS51172B (sr)	2010-10-31
US20070154998A1 (en)	2007-07-05
ATE434666T1 (de)	2009-07-15

Legal Events

Date	Code	Title	Description
2007-06-01	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2007-07-04	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2007-07-04	AX	Request for extension of the european patent	Extension state: AL BA HR MK YU
2008-02-06	17P	Request for examination filed	Effective date: 20071220
2008-02-27	17Q	First examination report despatched	Effective date: 20080129
2008-03-12	AKX	Designation fees paid	Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2008-03-12	AXX	Extension fees paid	Extension state: YU Payment date: 20071220 Extension state: MK Payment date: 20071220 Extension state: BA Payment date: 20071220 Extension state: AL Payment date: 20071220 Extension state: HR Payment date: 20071220
2009-01-23	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2009-05-13	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2009-05-22	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2009-06-24	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2009-06-24	AX	Request for extension of the european patent	Extension state: AL BA HR MK YU
2009-06-24	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2009-06-30	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2009-07-13	REG	Reference to a national code	Ref country code: GR Ref legal event code: EP Ref document number: 20090401665 Country of ref document: GR
2009-07-14	REG	Reference to a national code	Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20090707
2009-07-15	REG	Reference to a national code	Ref country code: CH Ref legal event code: NV Representative=s name: DR. JOACHIM LAUER PATENTANWALT
2009-07-22	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2009-07-29	REG	Reference to a national code	Ref country code: RO Ref legal event code: EPE
2009-08-06	REF	Corresponds to:	Ref document number: 602005015133 Country of ref document: DE Date of ref document: 20090806 Kind code of ref document: P
2009-09-08	REG	Reference to a national code	Ref country code: SE Ref legal event code: TRGR
2009-09-24	REG	Reference to a national code	Ref country code: HR Ref legal event code: TUEP Ref document number: P20090507 Country of ref document: HR
2009-10-08	REG	Reference to a national code	Ref country code: ES Ref legal event code: FG2A Ref document number: 2326379 Country of ref document: ES Kind code of ref document: T3
2009-10-12	REG	Reference to a national code	Ref country code: DK Ref legal event code: T3
2009-10-15	REG	Reference to a national code	Ref country code: EE Ref legal event code: FG4A Ref document number: E003516 Country of ref document: EE Effective date: 20090828
2009-10-31	REG	Reference to a national code	Ref country code: HR Ref legal event code: T1PR Ref document number: P20090507 Country of ref document: HR
2009-12-31	REG	Reference to a national code	Ref country code: PL Ref legal event code: T3
2010-03-01	REG	Reference to a national code	Ref country code: HU Ref legal event code: AG4A Ref document number: E006494 Country of ref document: HU
2010-04-30	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2010-04-30	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2010-06-02	26N	No opposition filed	Effective date: 20100325
2012-09-28	REG	Reference to a national code	Ref country code: CH Ref legal event code: PCAR Free format text: DR. JOACHIM LAUER C/O RENTSCH PARTNER AG;FRAUMUENSTERSTRASSE 9 POSTFACH 2441;8022 ZUERICH (CH)
2014-01-31	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: MC Payment date: 20131129 Year of fee payment: 9 Ref country code: IS Payment date: 20131223 Year of fee payment: 9
2014-02-28	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: LU Payment date: 20131219 Year of fee payment: 9
2015-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141229
2015-11-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150701
2015-12-31	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11
2016-05-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141231
2016-12-30	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12
2017-09-29	REG	Reference to a national code	Ref country code: CH Ref legal event code: PCAR Free format text: NEW ADDRESS: BELLERIVESTRASSE 203 POSTFACH, 8034 ZUERICH (CH)
2018-01-02	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13
2018-12-14	REG	Reference to a national code	Ref country code: HR Ref legal event code: ODRP Ref document number: P20090507 Country of ref document: HR Payment date: 20181129 Year of fee payment: 14
2020-01-10	REG	Reference to a national code	Ref country code: HR Ref legal event code: ODRP Ref document number: P20090507 Country of ref document: HR Payment date: 20191118 Year of fee payment: 15
2021-01-08	REG	Reference to a national code	Ref country code: HR Ref legal event code: ODRP Ref document number: P20090507 Country of ref document: HR Payment date: 20201116 Year of fee payment: 16
2022-01-07	REG	Reference to a national code	Ref country code: HR Ref legal event code: ODRP Ref document number: P20090507 Country of ref document: HR Payment date: 20211124 Year of fee payment: 17
2023-01-06	REG	Reference to a national code	Ref country code: HR Ref legal event code: ODRP Ref document number: P20090507 Country of ref document: HR Payment date: 20221202 Year of fee payment: 18
2023-01-31	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: SK Payment date: 20221116 Year of fee payment: 18 Ref country code: SE Payment date: 20221130 Year of fee payment: 18 Ref country code: RO Payment date: 20221125 Year of fee payment: 18 Ref country code: PT Payment date: 20221117 Year of fee payment: 18 Ref country code: NL Payment date: 20221222 Year of fee payment: 18 Ref country code: LV Payment date: 20221123 Year of fee payment: 18 Ref country code: LT Payment date: 20221117 Year of fee payment: 18 Ref country code: GB Payment date: 20221130 Year of fee payment: 18 Ref country code: FI Payment date: 20221215 Year of fee payment: 18 Ref country code: EE Payment date: 20221116 Year of fee payment: 18 Ref country code: AT Payment date: 20221227 Year of fee payment: 18
2023-02-28	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: SI Payment date: 20221123 Year of fee payment: 18 Ref country code: GR Payment date: 20221116 Year of fee payment: 18
2023-05-31	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: CY Payment date: 20221116 Year of fee payment: 18
2023-07-17	REG	Reference to a national code	Ref country code: EE Ref legal event code: HC1A Ref document number: E003516 Country of ref document: EE
2024-01-05	REG	Reference to a national code	Ref country code: HR Ref legal event code: ODRP Ref document number: P20090507 Country of ref document: HR Payment date: 20231120 Year of fee payment: 19
2024-07-25	REG	Reference to a national code	Ref country code: LT Ref legal event code: MM4D Effective date: 20231229
2024-07-30	REG	Reference to a national code	Ref country code: SE Ref legal event code: EUG
2024-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: RO Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231229 Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231229 Ref country code: CY Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231229
2024-08-07	REG	Reference to a national code	Ref country code: NL Ref legal event code: MM Effective date: 20240101
2024-08-14	REG	Reference to a national code	Ref country code: SK Ref legal event code: MM4A Ref document number: E 5977 Country of ref document: SK Effective date: 20231229
2024-08-15	REG	Reference to a national code	Ref country code: EE Ref legal event code: MM4A Ref document number: E003516 Country of ref document: EE Effective date: 20231231 Ref country code: AT Ref legal event code: MM01 Ref document number: 434666 Country of ref document: AT Kind code of ref document: T Effective date: 20231229
2024-08-28	GBPC	Gb: european patent ceased through non-payment of renewal fee	Effective date: 20231229
2024-08-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LV Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231229
2024-09-20	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240101
2024-09-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240101
2024-09-30	REG	Reference to a national code	Ref country code: SI Ref legal event code: KO00 Effective date: 20240819
2024-10-10	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231229
2024-10-11	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240712
2024-10-14	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240701 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231229
2024-10-23	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: EE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231231
2024-10-24	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231229
2024-10-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231230 Ref country code: SK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231229
2024-10-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231229 Ref country code: SI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231230 Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240701 Ref country code: LT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231229 Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240712 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231229 Ref country code: EE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231231 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231229
2025-01-03	REG	Reference to a national code	Ref country code: HR Ref legal event code: ODRP Ref document number: P20090507 Country of ref document: HR Payment date: 20241120 Year of fee payment: 20
2025-01-15	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: DK Payment date: 20241129 Year of fee payment: 20
2025-01-16	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: BE Payment date: 20241118 Year of fee payment: 20 Ref country code: PL Payment date: 20241120 Year of fee payment: 20
2025-01-20	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: FR Payment date: 20241128 Year of fee payment: 20 Ref country code: BG Payment date: 20241127 Year of fee payment: 20
2025-01-23	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: HU Payment date: 20241128 Year of fee payment: 20
2025-01-24	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: IE Payment date: 20241118 Year of fee payment: 20 Ref country code: CZ Payment date: 20241118 Year of fee payment: 20
2025-01-28	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: IT Payment date: 20241202 Year of fee payment: 20
2025-02-03	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: TR Payment date: 20241122 Year of fee payment: 20
2025-04-11	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: DE Payment date: 20241218 Year of fee payment: 20
2025-04-17	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: ES Payment date: 20250108 Year of fee payment: 20
2025-04-24	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: CH Payment date: 20250101 Year of fee payment: 20
2025-10-13	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231230
2025-12-29	REG	Reference to a national code	Ref country code: CH Ref legal event code: H14 Free format text: ST27 STATUS EVENT CODE: U-0-0-H10-H14 (AS PROVIDED BY THE NATIONAL OFFICE) Effective date: 20251229 Ref country code: DE Ref legal event code: R071 Ref document number: 602005015133 Country of ref document: DE
2026-01-02	REG	Reference to a national code	Ref country code: HR Ref legal event code: PB20 Ref document number: P20090507 Country of ref document: HR Effective date: 20251229
2026-01-05	REG	Reference to a national code	Ref country code: DK Ref legal event code: EUP Expiry date: 20251229
2026-01-08	REG	Reference to a national code	Ref country code: ES Ref legal event code: FD2A Effective date: 20260108
2026-01-16	REG	Reference to a national code	Ref country code: BE Ref legal event code: MK Effective date: 20251229
2026-01-20	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CZ Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20251229
2026-01-28	REG	Reference to a national code	Ref country code: IE Ref legal event code: MK9A
2026-01-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20251230
2026-04-13	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20251229

Publication	Publication Date	Title
Sato et al.	2001	Efficient production of menaquinone (vitamin K2) by a menadione-resistant mutant of Bacillus subtilis
EP1803820B1 (en)	2009-06-24	A process for the preparation of vitamin K2
US20240240213A1 (en)	2024-07-18	Bacillus natto for producing menaquinone-7 and use thereof
WO2018124135A1 (ja)	2018-07-05	ウロリチン類の製造方法
TWI724324B (zh)	2021-04-11	生產丁酸及／或其鹽類之方法
KR101888072B1 (ko)	2018-08-14	메나퀴논-７ 생성능이 향상된 신균주 바실러스 서브틸리스 ｂｓｍ-ｋ０２ 및 이를 이용한 메나퀴논-７의 대량 생산 방법
JP7225086B2 (ja)	2023-02-20	新規微生物、およびそれを用いたウロリチン類の製造方法
JP6053198B2 (ja)	2016-12-27	βグルカンの製造方法
JP7373402B2 (ja)	2023-11-02	ウロリチン類の製造方法
JP4264159B2 (ja)	2009-05-13	ビタミンｋ２高生産性納豆菌、その育種方法及び納豆
JP7211721B2 (ja)	2023-01-24	新規微生物及び該微生物を用いたウロリチン類の製造方法
JP4115181B2 (ja)	2008-07-09	乳酸菌の免疫賦活効果増強方法
KR20090088630A (ko)	2009-08-20	프로테우스 미라빌리스 유래 아미노산 탈아미노화 효소유전자, 단백질, 재조합 벡터 및 형질전환체, 및 이를사용하여 기능성 유기산을 제조하는 방법
JP4901113B2 (ja)	2012-03-21	乳酸菌の培養方法と乳酸菌培養物、飲料および食品、飼料および飼料添加物、医薬品
Frengova et al.	2004	Improvement of carotenoid-synthesizing yeast Rhodotorula rubra by chemical mutagenesis
CN115960767B (zh)	2024-04-26	一种植物乳植杆菌及其应用
JP2024056920A (ja)	2024-04-23	６－ヒドロキシダイゼインの製造方法
EP1001033A2 (fr)	2000-05-17	Procédé de production de farines lactiques et produits obtenus
JP4068103B2 (ja)	2008-03-26	雲南ｓｌ−００１菌の培養によるビタミンｋの生産方法
JPS62208277A (ja)	1987-09-12	イヌリナ−ゼの製造法
JP2014150731A (ja)	2014-08-25	メナキノン−７含有食品および微生物によるメナキノン−７の製造法
CZ20004105A3 (cs)	2002-01-16	Kmen mikroorganismu Nocardia sp.
JPWO2001036591A1 (ja)	2003-05-27	雲南ｓｌ−００１菌